Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience

INTRODUCTION: Daptomycin, a rapid concentration-dependent bactericidal antibiotic, is approved at a dose of 4 mg/kg/day for the treatment of complicated skin and soft tissue infections (cSSTI) and at a dose of 6 mg/kg/day for the treatment of Staphylococcus aureus right-sided infective endocarditis...

Descripción completa

Detalles Bibliográficos
Autores principales: Seaton, R. Andrew, Menichetti, Francesco, Dalekos, Georgios, Beiras-Fernandez, Andres, Nacinovich, Francisco, Pathan, Rashidkhan, Hamed, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679787/
https://www.ncbi.nlm.nih.gov/pubmed/26610384
http://dx.doi.org/10.1007/s12325-015-0267-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679787/
https://www.ncbi.nlm.nih.gov/pubmed/26610384
http://dx.doi.org/10.1007/s12325-015-0267-4

Ejemplares similares